StockData
Profound Medical Corp. logo

Profound Medical Corp. (PROF) stock

PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$6.91−0.17 (-2.40%)

Close on Nov 18, 2026Market cap $252.44MP/E –Yield –

Profound Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Profound Medical's operating income for the twelve months ending Jun 30, 2026 was -$35.37M. For fiscal 2025 it was -$41.25M. The highest annual figure on record is -$14.90M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$41.25M–
FY2024Dec 31, 2024-$33.06M–
FY2023Dec 31, 2023-$28.65M–
FY2022Dec 31, 2022-$32.13M–
FY2021Dec 31, 2021-$30.29M–
FY2020Dec 31, 2020-$18.86M–
FY2019Dec 31, 2019-$14.90M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$11.07M–
Q1 FY2026Mar 31, 2026-$8.02M–
Q4 FY2025Dec 31, 2025-$7.37M–
Q3 FY2025Sep 30, 2025-$8.91M–
Q2 FY2025Jun 30, 2025-$13.81M–
Q1 FY2025Mar 31, 2025-$11.17M–
Q4 FY2024Dec 31, 2024-$8.35M–
Q3 FY2024Sep 30, 2024-$9.00M–
Q2 FY2024Jun 30, 2024-$7.84M–
Q1 FY2024Mar 31, 2024-$7.88M–

More Profound Medical figures

See a number that looks wrong?